MRC1 and chronic kidney disease: In the transition from acute kidney injury (AKI) to chronic kidney disease (CKD), the SGK3/TOPK signaling pathway has been shown to exhibit a counteractive effect, promoting fibrosis in renal tubular epithelial cells and CD206 M2 macrophage polarization [52].